Literature DB >> 34917243

BRD9 Bifunctional Degraders for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917243      PMCID： PMC8667060          DOI： 10.1021/acsmedchemlett.1c00580

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors.

Authors:  Oliver Bechter; Patrick Schöffski
Journal:  Pharmacol Ther       Date:  2020-01-11       Impact factor: 12.310

Review 2.  Bromodomains: A novel target for the anticancer therapy.

Authors:  Shivani Gokani; Lokesh Kumar Bhatt
Journal:  Eur J Pharmacol       Date:  2021-09-23       Impact factor: 4.432

Review 3.  Targeting BRD9 for Cancer Treatment: A New Strategy.

Authors:  Xiuzuo Zhu; Yi Liao; Liling Tang
Journal:  Onco Targets Ther       Date:  2020-12-24       Impact factor: 4.147

Review 4.  The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.

Authors:  Motoyuki Tsuda; Akihisa Fukuda; Munenori Kawai; Osamu Araki; Hiroshi Seno
Journal:  Cancer Sci       Date:  2020-12-28       Impact factor: 6.716

Review 5.  Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.

Authors:  Francesca D'Amico; Rishov Mukhopadhyay; Huib Ovaa; Monique P C Mulder
Journal:  Chembiochem       Date:  2021-03-18       Impact factor: 3.164

Review 6.  Exploiting epigenetic dependencies in ovarian cancer therapy.

Authors:  Aisling Y Coughlan; Giuseppe Testa
Journal:  Int J Cancer       Date:  2021-08-06       Impact factor: 7.316
  6 in total
  4 in total

1.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

2.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Med Chem Lett       Date:  2022-10-13       Impact factor: 4.632

Review 3.  Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening.

Authors:  Federica Pedrucci; Claudia Pappalardo; Giovanni Marzaro; Nicola Ferri; Alberto Ferlin; Luca De Toni
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 4.  Discovery of E3 Ligase Ligands for Target Protein Degradation.

Authors:  Jaeseok Lee; Youngjun Lee; Young Mee Jung; Ju Hyun Park; Hyuk Sang Yoo; Jongmin Park
Journal:  Molecules       Date:  2022-10-02       Impact factor: 4.927
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.